col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


65 Results       Page 1

 [1] 
Wiley: Clinical & Translational Immunology
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―15 SARS-CoV-2-infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses Ying Wang, Melissa Thaler, Clarisse Salgado-Benvindo, Nathan Ly, Anouk A Leijs, Dennis K Ninaber, et al. (+6)
2 [GO] 2024―Feb―07 Whole transcriptome profiling of placental pathobiology in SARS-CoV-2 pregnancies identifies placental dysfunction signatures Nataly Stylianou, Ismail Sebina, Nicholas Matigian, James Monkman, Hadeel Doehler, Joan Röhl, et al. (+22)
3 [GO] 2024―Feb―01 SARS-CoV-2-associated T-cell infiltration in the central nervous system Malte Mohme, Christoph Schultheiß, Andras Piffko, Antonia Fitzek, Lisa Paschold, Benjamin Thiele, et al. (+6)
4 [GO] 2023―Dec―03 Elevated BMI reduces the humoral response to SARS-CoV-2 infection Marcus ZW Tong, Julian DJ Sng, Meagan Carney, Lucy Cooper, Samuel Brown, Katie E Lineburg, et al. (+17)
5 [GO] 2023―Nov―25 Plasma SARS-CoV-2 RNA elimination and RAGE kinetics distinguish COVID-19 severity Xiaoyan Deng, Pierre Gantner, Julia Forestell, Amélie Pagliuzza, Elsa Brunet-Ratnasingham, Madeleine Durand, et al. (+3)
6 [GO] 2023―Aug―28 A unique cytotoxic CD4+ T cell-signature defines critical COVID-19 Sarah Baird, Caroline L Ashley, Felix Marsh-Wakefield, Sibel Alca, Thomas M Ashhurst, Angela L Ferguson, et al. (+14)
7 [GO] 2022―Oct―23 Heterologous SARS-CoV -2 IgA neutralising antibody responses in convalescent plasma Samantha K Davis, Kevin John Selva, Ester Lopez, Ebene R Haycroft, Wen Shi Lee, Adam K Wheatley, et al. (+9)
8 [GO] 2022―Oct―22 Targeting SARS-CoV -2 infection through CAR-T -like bispecific T cell engagers incorporating ACE2 Mikail Dogan, Lina Kozhaya, Lindsey Placek, Fatih Karabacak, Mesut Yigit, Derya Unutmaz
9 [GO] 2022―Oct―15 Parallel detection of SARS-CoV -2 epitopes reveals dynamic immunodominance profiles of CD8 + T memory cells in convalescent COVID -19 donors Jet van den Dijssel, Ruth R Hagen, Rivka de Jongh, Maurice Steenhuis, Theo Rispens, Dionne M Geerdes, et al. (+10)
10 [GO] 2022―Aug―18 SARS-CoV -2 triggers complement activation through interactions with heparan sulfate Martin W Lo, Alberto A Amarilla, John D Lee, Eduardo A Albornoz, Naphak Modhiran, Richard J Clark, et al. (+5)
11 [GO] 2022―Aug―12 Previous SARS-CoV -2 infection or a third dose of vaccine elicited cross-variant neutralising antibodies in vaccinated solid-organ transplant recipients Chih-Chao Chang, George Vlad, Elena Rodica Vasilescu, Ping Li, Syed A Husain, Elaine A Silvia, et al. (+5)
12 [GO] 2022―May―16 Organ-specific immune response in lethal SARS-CoV-2 infection by deep spatial phenotyping Akhila Balachander, Bernett Lee, Subhra K Biswas, David C Lye, Raymond TP Lin, Yee-Sin Leo, et al. (+3)
13 [GO] 2022―Apr―29 Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine Kapil K Saharia, Jennifer S Husson, Silke V Niederhaus, Thierry Iraguha, Stephanie V Avila, Youngchae J Yoo, et al. (+21)
14 [GO] 2022―Apr―26 Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccination Deidre Wilkins, Anastasia A Aksyuk, Alexey Ruzin, Kevin M Tuffy, Tina Green, Rebecca Greway, et al. (+4)
15 [GO] 2022―Apr―22 Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19 Nicole L Messina, Susie Germano, Rebecca McElroy, Rajeev Rudraraju, Rhian Bonnici, Laure F Pittet, et al. (+532)
16 [GO] 2022―Apr―18 Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time Sebastian Havervall, Ulrika Marking, Nina Greilert-Norin, Max Gordon, Henry Ng, Wanda Christ, et al. (+8)
17 [GO] 2022―Apr―17 Severe COVID-19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals Paul E Gray, Adam W Bartlett, Stuart G Tangye
18 [GO] 2022―Mar―23 A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination Karen Colwill, Yannick Galipeau, Matthew Stuible, Christian Gervais, Corey Arnold, Bhavisha Rathod, et al. (+25)
19 [GO] 2022―Jan―30 Quantitative measurement of IgG to SARS-CoV-2 antigens using monoclonal antibody-based enzyme-linked immunosorbent assays Ingrid Sander, Sabine Kespohl, Eva Zahradnik, Philipp Göcke, Ingolf Hosbach, Burkhard L Herrmann, et al. (+2)
20 [GO] 2022―Jan―12 Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID-19 lung disease Sarita Rani Jaiswal, Jaganath Arunachalam, Ashutosh Bhardwaj, Ashraf Saifullah, Rohit Lakhchaura, Mayank Soni, et al. (+2)
21 [GO] 2022―Jan―12 Whole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate Stephen C De Rosa, Kristen W Cohen, Matthew Bonaparte, Bo Fu, Sanjay Garg, Catherine Gerard, et al. (+8)
22 [GO] 2021―Dec―12 Blunted sFasL signalling exacerbates TNF-driven neutrophil necroptosis in critically ill COVID-19 patients Tiziano A Schweizer, Srikanth Mairpady Shambat, Clement Vulin, Sylvia Hoeller, Claudio Acevedo, Markus Huemer, et al. (+12)
23 [GO] 2021―Nov―01 Tear antibodies to SARS-CoV-2: implications for transmission Kevin J Selva, Samantha K Davis, Ebene R Haycroft, Wen Shi Lee, Ester Lopez, Arnold Reynaldi, et al. (+5)
24 [GO] 2021―Oct―25 Endothelial cells are not productively infected by SARS-CoV-2 Lilian Schimmel, Keng Yih Chew, Claudia J Stocks, Teodor E Yordanov, Patricia Essebier, Arutha Kulasinghe, et al. (+9)
25 [GO] 2021―Sep―09 T-cell response after first dose of BNT162b2 SARS-CoV-2 vaccine among healthcare workers with previous infection or cross-reactive immunity Jose L Casado, Johannes Haemmerle, Pilar Vizcarra, Mario Rodriguez-Dominguez, Tamara Velasco, Hector Velasco, et al. (+4)
26 [GO] 2021―Sep―07 Cardiovascular disease in SARS-CoV-2 infection Kei Sato, Jane E Sinclair, Habib Sadeghirad, John F Fraser, Kirsty R Short, Arutha Kulasinghe
27 [GO] 2021―Sep―06 SARS-CoV-2 sculpts the immune system to induce sustained virus-specific naïve-like and memory B-cell responses Leire de Campos-Mata, Sonia Tejedor Vaquero, Roser Tachó-Piñot, Janet Piñero, Emilie K Grasset, Itziar Arrieta Aldea, et al. (+6)
28 [GO] 2021―Aug―28 Landscape of T-cell repertoires with public COVID-19-associated T-cell receptors in pre-pandemic risk cohorts Donjete Simnica, Christoph Schultheiß, Malte Mohme, Lisa Paschold, Edith Willscher, Antonia Fitzek, et al. (+11)
29 [GO] 2021―Aug―17 Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients David Goncalves, Mehdi Mezidi, Paul Bastard, Magali Perret, Kahina Saker, Nicole Fabien, et al. (+7)
30 [GO] 2021―Aug―12 Rapid whole-blood assay to detect SARS-CoV-2-specific memory T-cell immunity following a single dose of AstraZeneca ChAdOx1-S COVID-19 vaccine Katie E Lineburg, Michelle A Neller, George R Ambalathingal, Laetitia Le Texier, Jyothy Raju, Srividhya Swaminathan, et al. (+8)
31 [GO] 2021―Jul―27 Decline in neutralising antibody responses, but sustained T-cell immunity, in COVID-19 patients at 7 months post-infection Jun Chen, Xiaomin Liu, Xinyu Zhang, Yixiao Lin, Danping Liu, Jingna Xun, et al. (+6)
32 [GO] 2021―Jul―19 Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay Sophia Hober, Cecilia Hellström, Jennie Olofsson, Eni Andersson, Sofia Bergström, August Jernbom Falk, et al. (+44)
33 [GO] 2021―Jul―05 SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation John Tyler Sandberg, Renata Varnaitė, Wanda Christ, Puran Chen, Jagadeeswara R Muvva, Kimia T Maleki, et al. (+72)
34 [GO] 2021―Jul―01 No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID-19 disease José Alquicira-Hernandez, Joseph E Powell, Tri Giang Phan
35 [GO] 2021―Jun―06 Genetic risk for severe COVID-19 correlates with lower inflammatory marker levels in a SARS-CoV-2-negative cohort Timothy R Powell, Matthew Hotopf, Stephani L Hatch, Gerome Breen, Rodrigo RR Duarte, Douglas F Nixon
36 [GO] 2021―May―17 Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors Maurice Steenhuis, Gerard Mierlo, Ninotska IL Derksen, Pleuni Ooijevaar-de Heer, Simone Kruithof, Floris L Loeff, et al. (+15)
37 [GO] 2021―May―07 Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals Alessio Mazzoni, Laura Maggi, Manuela Capone, Anna Vanni, Michele Spinicci, Lorenzo Salvati, et al. (+10)
38 [GO] 2021―Apr―29 Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019 Mieke Metzemaekers, Seppe Cambier, Marfa Blanter, Jennifer Vandooren, Ana Carolina Carvalho, Bert Malengier-Devlies, et al. (+37)
39 [GO] 2021―Apr―05 Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2 Daniel Watterson, Danushka K Wijesundara, Naphak Modhiran, Francesca L Mordant, Zheyi Li, Michael S Avumegah, et al. (+44)
40 [GO] 2021―Mar―18 RGD-binding integrins and TGF-β in SARS-CoV-2 infections - novel targets to treat COVID-19 patients? Ingrid Carvacho, Matthias Piesche
41 [GO] 2021―Mar―17 Adaptive immunity to human coronaviruses is widespread but low in magnitude Hyon-Xhi Tan, Wen Shi Lee, Kathleen M Wragg, Christina Nelson, Robyn Esterbauer, Hannah G Kelly, et al. (+21)
42 [GO] 2021―Mar―14 Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand Alana L Whitcombe, Reuben McGregor, Alyson Craigie, Alex James, Richard Charlewood, Natalie Lorenz, et al. (+13)
43 [GO] 2021―Mar―07 Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2 Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, Ahmed O Shalash, Michael A Joyce, Holly A Saffran, et al. (+16)
44 [GO] 2021―Mar―04 Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study Jingyi Yang, Maohua Zhong, Ke Hong, Qingyu Yang, Ejuan Zhang, Dihan Zhou, et al. (+12)
45 [GO] 2021―Feb―28 Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features Louise C Rowntree, Brendon Y Chua, Suellen Nicholson, Marios Koutsakos, Luca Hensen, Celia Douros, et al. (+20)
46 [GO] 2021―Feb―22 Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant Cheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, Yun Shan Goh, Tze-Minn Mak, Sophie Octavia, et al. (+19)
47 [GO] 2021―Feb―18 High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses Min Xie, Joseph Yunis, Yin Yao, Jing Shi, Yang Yang, Pengcheng Zhou, et al. (+18)
48 [GO] 2021―Feb―01 Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19 Maria Byazrova, Gaukhar Yusubalieva, Anna Spiridonova, Grigory Efimov, Dmitriy Mazurov, Konstantin Baranov, et al. (+2)
49 [GO] 2021―Jan―26 Influenza, but not SARS-CoV-2, infection induces a rapid interferon response that wanes with age and diminished tissue-resident memory CD8 + T cells Thi HO Nguyen, Julie L McAuley, Youry Kim, Ming ZM Zheng, Nicholas A Gherardin, Dale I Godfrey, et al. (+6)
50 [GO] 2020―Dec―24 Severe SARS-CoV-2 patients develop a higher specific T-cell response Julie Demaret, Guillaume Lefèvre, Fanny Vuotto, Jacques Trauet, Alain Duhamel, Julien Labreuche, et al. (+27)
51 [GO] 2020―Dec―23 Trained immunity as a novel approach against COVID-19 with a focus on Bacillus Calmette-Guérin vaccine: mechanisms, challenges and perspectives Yahya Sohrabi, Jéssica Cristina Dos Santos, Marc Dorenkamp, Hannes Findeisen, Rinesh Godfrey, Mihai G Netea, Leo AB Joosten
52 [GO] 2020―Dec―14 Innate lymphoid cell composition associates with COVID-19 disease severity Marina García, Efthymia Kokkinou, Anna Carrasco García, Tiphaine Parrot, Laura M Palma Medina, Kimia T Maleki, et al. (+14)
53 [GO] 2020―Dec―10 Identification of similar epitopes between severe acute respiratory syndrome coronavirus-2 and Bacillus Calmette-Guérin: potential for cross-reactive adaptive immunity Szabolcs Urbán, Gábor Paragi, Katalin Burián, Gary R McLean, Dezső P Virok
54 [GO] 2020―Dec―07 Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases Katie E Lineburg, Sriganesh Srihari, Mohammed Altaf, Srividhya Swaminathan, Archana Panikkar, Jyothy Raju, et al. (+7)
55 [GO] 2020―Nov―26 Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab Armando Caballero, Lázaro M Filgueira, Julio Betancourt, Naivy Sánchez, Carlos Hidalgo, Alberto Ramírez, et al. (+22)
56 [GO] 2020―Nov―13 Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19 Julika Neumann, Teresa Prezzemolo, Lore Vanderbeke, Carlos P Roca, Margaux Gerbaux, Silke Janssens, et al. (+30)
57 [GO] 2020―Oct―16 Intravenous immunoglobulin immunotherapy for coronavirus disease-19 (COVID-19) Caroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
58 [GO] 2020―Oct―14 Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study Ziyun Shao, Yongwen Feng, Li Zhong, Qifeng Xie, Ming Lei, Zheying Liu, et al. (+8)
59 [GO] 2020―Oct―08 Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity Nancy R Graham, Annalis N Whitaker, Camilla A Strother, Ashley K Miles, Dore Grier, Benjamin D McElvany, et al. (+10)
60 [GO] 2020―Oct―01 Immunosuppression and cardiovascular dysfunction in patients with severe versus mild coronavirus disease 2019: a case series Hejing Bao, Gang Li, Yinhua Fang, Qin Lai, Hehong Bao, Yu Zheng, Yanjun Hu
61 [GO] 2020―Sep―27 Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Chuanhao Jiang, Yali Wang, Min Hu, Lingjun Wen, Chuan Wen, Yang Wang, et al. (+8)
62 [GO] 2020―Jul―28 Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection Pei Hua Lee, Woo Chiao Tay, Stephanie Sutjipto, Siew-Wai Fong, Sean Wei Xiang Ong, Wycliff Enli Wei, et al. (+9)
63 [GO] 2020―Jul―26 Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019 Sean Wei Xiang Ong, Wilnard Yeong Tze Tan, Yi-Hao Chan, Siew-Wai Fong, Laurent Renia, Lisa FP Ng, et al. (+3)
64 [GO] 2020―May―11 Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence Sheng Zhang, Jun Gan, Bao-Guo Chen, Dan Zheng, Jian-Gang Zhang, Rong-Hai Lin, et al. (+4)
65 [GO] 2020―May―06 Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 Hongyan Hou, Ting Wang, Bo Zhang, Ying Luo, Lie Mao, Feng Wang, et al. (+2)
 [1] 

65 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec